HomeENTO • NASDAQ
Entero Therapeutics Inc
add
$0.49
0.00%
Pre-market:(9.47%)-0.046
$0.44
Closed: Apr 8, 8:13:46 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.20M | -70.60% |
Net income | -12.24M | -198.43% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.20M | 70.69% |
Effective tax rate | -888.11% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 163.48K | -95.60% |
Total assets | 85.41M | 1,140.84% |
Total liabilities | 27.61M | 741.55% |
Total equity | 57.80M | — |
Shares outstanding | 4.77M | — |
Price to book | -0.60 | — |
Return on assets | -3.51% | — |
Return on capital | -4.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.24M | -198.43% |
Cash from operations | -171.52K | 95.01% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -31.80K | -100.73% |
Net change in cash | -203.32K | -148.47% |
Free cash flow | 5.12M | 249.03% |
Previous close
$0.49
Year range
$0.19 - $3.16
Market cap
2.34M USD
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
2
